相关实验视频
Updated: Jun 26, 2025

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
366
肥胖药物:对当前和新兴药物的叙事性审查
Q Y D Qi1,2, A Cox1, S McNeil1
1Department of Endocrinology and Diabetes, Alfred Health, Victoria, Australia.
Osteoarthritis and cartilage open
|May 13, 2024
概括
新的肥胖药物,如西马格卢提德和蒂尔泽帕提德,提供显著的减肥 (15-20%) 和健康益处超越老药物. 未来的治疗方法旨在扩大获取范围和长期的体重管理策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 内分泌学 在内分泌学.
- 肥胖医学 肥胖医学
背景情况:
- 肥胖是一种复杂的慢性疾病,需要有效的长期管理策略.
- 目前针对肥胖的药物治疗包括与已批准的药物相结合的生活方式干预措施.
研究的目的:
- 审查已批准的肥胖管理药物的疗效和安全性.
- 为体重管理提供新兴药理学药物的前景.
主要方法:
- 从PubMed,Medline和Embase数据库中对文献进行叙事审查.
- 包括主要监管地区批准药物的第三阶段临床试验和元分析.
主要成果:
- 经批准的肥胖药物可以促进长期减肥,并改善心脏代谢风险因素,而仅仅是生活方式干预.
- 较旧的药物产生5-10%的体重减轻,而新的药物如西马格卢提德和蒂尔泽帕提德可以实现15-20%的减轻.
- 新兴的治疗方法包括多激素受体激动剂和口服配方.
结论:
- 药理干预对于有效的肥胖管理至关重要,新药显示出更高的疗效.
- 未来的研究和临床实践必须解决公平获取,成本和重量恢复和身体组成的长期策略.
- 新的治疗标和传递方法正在开发中,用于治疗肥胖症.
相关概念视频
Obesity
468
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
468
Antidepressant Drugs: MAOIs and Other Agents
226
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
226
Oral Hypoglycemic Agents: Biguanides and Glitazones
192
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
192
Glucagon-like Receptor Agonists
318
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
318
Oral Hypoglycemic Agents: Glinides
153
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
153
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
652
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
652

